Daytrana and educational problem Patient Reports February 13, 2012
Daytrana Side Effects Report #5292688-0
Daytrana side effect was reported by a Physician from UNITED STATES on Mar 22, 2007. Male patient, 13 years of age, weighting 183.0 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: aggression, educational problem, legal problem, suicidal ideation. Daytrana dosage: unknown. Patient recovered.
Daytrana Side Effects Report #5261945-6
Daytrana side effect was reported by a Physician from UNITED STATES on Feb 27, 2007. Male patient, child 11 years of age, weighting 84.00 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: abnormal behaviour, depression
, educational problem, suicidal ideation. Daytrana dosage: 10 MG, TRANSDERMAL. Patient recovered.Daytrana Side Effects Report #5680835-8
Daytrana side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2008. Male patient, child 10 years of age, weighting 69.89 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: decreased appetite, disturbance in attention, educational problem, growth accelerated, increased appetite, pelvi-ureteric obstruction. Daytrana dosage: 10 MG, 1X/DAY:QD, TRANSDERMAL; 15 MG, 1X/DAY:QD, TRANSDERMAL; 20 MG, 1X/DAY:QD, TRANSDERMAL. During the same period patient was treated with LEXAPRO. Patient was hospitalized. Patient recovered.
Daytrana Side Effects Report #5713320-5
Daytrana side effect was reported by a Health Professional from UNITED STATES on Apr 08, 2008. Male patient, child 10 years of age, weighting 69.89 lb, was diagnosed with attention deficit/hyperactivity disorder and was treated with Daytrana. After drug was administered, patient experienced the following side effects: decreased appetite, educational problem, growth accelerated, increased appetite, pelvi-ureteric obstruction. Daytrana dosage: 10 MG, 1X/DAY;QD, TRANSDERMAL; 15 MG, 1X/DAY;QD, TRANSDERMAL; 20 MG, 1X/DAY, QD, TRANSDERMAL. During the same period patient was treated with LEXAPRO. Patient was hospitalized. Patient recovered.
Daytrana and educational problem 